RIVA Posterior Fixation System with NanoACTIV Surface Technology; RIVA Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology
Xenix Medical · Decision date Sep 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-14 for K262193, a traditional 510(k) submitted 06/29/2026 by Xenix Medical of Orlando, Florida. The device is listed as the RIVA® Posterior Fixation System with NanoACTIV Surface Technology and the RIVA® Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology, under device classification Thoracolumbosacral Pedicle Screw System, regulation 888.3070, product code NKB, with subsequent product codes KWQ, OLO and OUR. The orthopedic panel reviewed it; it was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized. SESE means clearance, not PMA approval.
The available records do not establish what, if anything, changed relative to a predicate device, nor do they give the full indications, performance data or labeling. One document excerpt references sacroiliac joint fusion for the Anchor system and immobilization and stabilization of spinal segments for the Posterior Fixation System, but the excerpt is truncated and the complete indications remain in the FDA documents. No clinical or comparative conclusions are drawn here.
The public record also does not identify the predicate device, the basis for the equivalence determination, or any conditions of clearance. Readers needing those details should consult the decision letter and the cleared labeling rather than this summary.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262193
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Xenix Medical
- Product code
- NKB
- Decision code
- SESE
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Thoracolumbosacral Pedicle Screw System.
- Applicant
- Xenix Medical
- Product code
- NKB
- FDA device class
- 2
FDA decision timeline
K262193 received
Application receipt date recorded by FDA.
K262193 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NKB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| SeaSpine Orthopedics Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| GS Medical Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA | |
NOVIX Pedicle Screw SystemK263062 | Tdm Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA |
Duet Spinal Fixation SystemK262712 | Duet Spine Holdings, LLC | 510(k) clearance | Sep 30, 2026 | FDA |
| Spinal Alignment Solutions, Inc. | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Xenix Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Orlando, FL
Sources and methodology
- Original FDA record: K262193
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


